[ad_1]
hapabapa/iStock Editorial through Getty Photographs
Novo Nordisk (NVO) has reportedly been criticized by the U.Okay.’s Prescription Medicines Code of Follow Authority, or PMCPA, for mischaracterizing sure funds to sufferers and healthcare teams.
The group, a self-regulatory physique which administers the Affiliation of the British Pharmaceutical Business’s
[ad_2]
Source link
